![]() |
市場調査レポート
商品コード
1622373
網膜硝子体手術装置市場規模、シェア、成長分析、製品タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025~2032年Vitreoretinal Surgery Devices Market Size, Share, Growth Analysis, By Product Type (Vitrectomy Packs, Vitrectomy Machines), By Application (Diabetic Retinopathy, Retinal Detachment), By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
網膜硝子体手術装置市場規模、シェア、成長分析、製品タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025~2032年 |
出版日: 2024年12月23日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
網膜硝子体手術装置市場規模は2023年に23億1,000万米ドルと評価され、2024年の24億4,000万米ドルから2032年には38億6,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは5.84%で成長する見通しです。
世界の網膜硝子体手術装置市場は、糖尿病性網膜症、黄斑変性症、網膜剥離などの網膜疾患の増加に牽引され、大きな成長を遂げています。この拡大を後押しする要因としては、手術技術の進歩、高齢者人口の増加、目の健康に対する意識の高まりなどが挙げられます。微小切開硝子体手術システムや3D可視化などの革新的技術は、精度と患者の予後を改善する低侵襲手術を容易にすることで、網膜硝子体手術に変革をもたらしつつあります。この市場には、最先端のソリューションを導入するための研究開発に注力する既存企業と新興企業が混在しています。メーカー各社がアンメット・メディカル・ニーズを満たし、手術結果の向上を目指していることから、市場の見通しは引き続き堅調であり、眼科医療ソリューションの継続的な進歩が期待されます。
Vitreoretinal Surgery Devices Market size was valued at USD 2.31 Billion in 2023 and is poised to grow from USD 2.44 Billion in 2024 to USD 3.86 Billion by 2032, growing at a CAGR of 5.84% during the forecast period (2025-2032).
The global vitreoretinal surgery devices market is witnessing significant growth, driven by an increase in retinal disorders such as diabetic retinopathy, macular degeneration, and retinal detachment. Factors fueling this expansion include advancements in surgical techniques, a rising geriatric population, and heightened awareness of eye health. Innovative technologies, including microincisional vitrectomy systems and 3D visualization, are transforming vitreoretinal surgery by facilitating minimally invasive procedures with improved precision and patient outcomes. The market features a mix of established companies and emerging players focused on research and development to introduce cutting-edge solutions. As manufacturers aim to meet unmet medical needs and enhance surgical results, the market's outlook remains robust, promising continued advancements in eye care solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Vitreoretinal Surgery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Vitreoretinal Surgery Devices Market Segmental Analysis
Global Vitreoretinal Surgery Devices Market is segmented by product type, application, end user and region. Based on product type, the market is segmented into vitrectomy packs, vitrectomy machines, photocoagulation lasers, illumination devices and surgical instruments. Based on application, the market is segmented into diabetic retinopathy, retinal detachment, macular hole, macular degeneration and others. Based on end user, the market is segmented into hospitals, ophthalmic clinics and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Vitreoretinal Surgery Devices Market
The expansion of the global aging population is significantly driving the Vitreoretinal Surgery Devices market. As people age, they become more susceptible to age-related eye disorders, including macular degeneration and diabetic retinopathy, which heightens the need for vitreoretinal surgeries. This demographic shift leads to an increased demand for specialized surgical devices aimed at treating these conditions, as such procedures are crucial for preserving and enhancing visual health in older individuals. Consequently, the growing prevalence of eye diseases associated with aging is creating a robust market for vitreoretinal surgery devices, emphasizing their importance in contemporary ophthalmic care.
Restraints in the Vitreoretinal Surgery Devices Market
The Vitreoretinal Surgery Devices market faces notable constraints primarily due to high costs associated with the devices and the procedures they entail. The expenses cover not only the specialized equipment and consumables but also the need for highly skilled medical personnel. Such financial burdens can restrict patient access to these advanced treatments, especially in areas with limited healthcare resources and tighter budgets. Consequently, this financial barrier poses a significant challenge to the growth and development of the market, as it can hinder the ability of healthcare facilities to invest in these vital technologies and services.
Market Trends of the Vitreoretinal Surgery Devices Market
The Vitreoretinal Surgery Devices market is witnessing a robust upward trend fueled by rapid technological advancements and innovative breakthroughs. The integration of robotic-assisted surgical systems, high-definition visualization tools, and minimally invasive techniques is revolutionizing the approach to vitreoretinal procedures, significantly improving precision and patient safety. These developments not only enhance surgical outcomes but also increase operational efficiency, making them attractive to both healthcare providers and patients. As a result, there is a growing demand for advanced vitreoretinal devices, which, coupled with a rise in ocular diseases, is expected to drive substantial market growth in the coming years.